Kelvin Cooper, Ph.D., C.Chem., FRSC, Elevated to Chief Executive Officer and Peter Ceccacci Promoted to Chief Financial Officer at Lakewood-Amedex Inc.
Position
Chief Financial Officer
Company
Lakewood-Amedex, Inc.
Description
Lakewood-Amedex Inc. announced the elevation of Kelvin Cooper to Chief Executive Officer and the promotion of Peter Ceccacci to Chief Financial Officer. These leadership changes aim to drive the company's portfolio of first-in-class Bisphosphocin® molecules and advance its Research and Clinical Development programs.
Quick answer
Kelvin Cooper, Ph.D., C.Chem., FRSC, Elevated to Chief Executive Officer and Peter Ceccacci Promoted to Chief Financial Officer at Lakewood-Amedex Inc. (February 12, 2025). Lakewood-Amedex, Inc. is based in University Park, Florida, United States.
- Who is the new Chief Financial Officer at Lakewood-Amedex, Inc?
- Lakewood-Amedex, Inc. named Peter Ceccacci Chief Financial Officer, announced February 12, 2025.
- What did Lakewood-Amedex, Inc. announce on February 12, 2025?
- Lakewood-Amedex Inc. announced the elevation of Kelvin Cooper to Chief Executive Officer and the promotion of Peter Ceccacci to Chief Financial Officer. These leadership changes aim to drive the company's portfolio of first-in-class Bisphosphocin® molecules and advance its Research and Clinical Development programs.
- What does Lakewood-Amedex, Inc. do?
- Lakewood-Amedex is a privately held pharmaceutical company that has discovered a novel class of antimicrobial agents called Bisphosphocins™.
- Where is Lakewood-Amedex, Inc. based?
- Lakewood-Amedex, Inc. is based in University Park, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Terns Pharmaceuticals (February 25, 2025), Crinetics Pharmaceuticals (February 26, 2025), Harrow (January 7, 2025) and Amylyx Pharmaceuticals (January 6, 2025) also announced leadership changes within 45 days of Lakewood-Amedex, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer (February 25, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Harrow Appoints Amir H. Shojaei as Chief Scientific Officer (January 7, 2025)
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
- Alcami Appoints Tori E. Arens as President of Drug Product (February 12, 2025)
- Revelation Pharma Promotes Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs (February 12, 2025)
Who to call at Lakewood-Amedex, Inc., and when
A new leader at Lakewood-Amedex, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lakewood-Amedex, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lakewood-Amedex, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lakewood-Amedex, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lakewood-Amedex, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lakewood-Amedex, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.